FDA Adverse Event Injury Summary report: N

PROTEGE RX CAROTID STENT SYSTEM

MDR report key: 7365922 · Received March 23, 2018

Report

Report Number
2183870-2018-00150
Event Type
Injury
Date Received
March 23, 2018
Date of Event
October 20, 2017
Report Date
March 23, 2018
Manufacturer
COVIDIEN
Product Code
NIM
PMA / PMN Number
P060001
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AVERAGE AGE, MAJORITY GENDER,EVENT DATE IS LITERATURE ARTICLE PUBLISHED ONLINE DATE   RECURRENT STENOSIS FOLLOWING CAROTID ARTERY STENTING TREATED WITH A DRUG-ELUTING BALLOON: A SINGLE-CENTER RETROSPECTIVE ANALYSIS C. POHLMANN & J. HÖLTJE & M. ZEILE & F. BONK & P. P. URBAN & R. BRÜNING NEURORADIOLOGY (2018) 60:81¿87 DOI.ORG/10.1007/S00234-017-1935-7. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

THE JOURNAL DOCUMENTS A RETROSPECTIVE SINGLE CENTER ANALYSIS OF PATIENTS WITH CAROTID ARTERY STENTING BETWEEN 2009 AND 2015. NINE PATIENTS WITH HIGH-GRADE CAROTID ARTERY IN STENT RESTENOSIS WERE IDENTIFIED. IN THE ORIGINAL INDEX PROCEDURES, ALL PATIENTS HAD CAROTID ARTERY STENTING CARRIED OUT. A PROTEGE CAROTID STENT WAS USED IN ONE PATIENT WHILE NON-MDT DEVICES WERE USED IN THE OTHER EIGHT PATIENTS. RESTENOSIS OCCURRED IN ALL PATIENTS POST PROCEDURE. ALL NINE PATIENTS WERE THEN RETREATED USING DRUG ELUTING BALLOONS. MEDTRONIC IN.PACT AMPHIPRION BALLOONS WERE USED IN FIVE OF THESE PROCEDURES. RESTENOSIS OCCURRED IN ONE PATIENT DURING THE FOLLOW UP PERIOD POST DEB TREATMENT. THERE WERE NO PRODUCT PROBLEMS AND NO OTHER ADVERSE EVENTS REPORTED IN CASES WHERE A MEDTRONIC DEVICE WAS USED. TWO DEATHS OCCURRED DURING THE FOLLOW UP PERIOD: ONE DECEASED DUE TO A BRONCHIAL CARCINOMA AND THE OTHER DECEASED DUE TO UROSEPSIS. BOTH DEATHS WERE UNRELATED TO THE DEB TREATMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
210554 PROTEGE RX CAROTID STENT SYSTEM STENT, CAROTID NIM COVIDIEN

Patients

Seq Age Sex Outcome Treatment
1 66 YR Required Intervention